Identification of A Disintegrin and Metalloproteinase 9 domain (ADAM9) required in the early stages of encephalomyocarditis virus infection
L. E. Bazzone, M. King, C. R. MacKay, P. P. Kyawe, P. Meraner, D. Lindstrom, J. Rojas-Quintero, C. A. Owen, J. P. Wang, A. L. Brass, E. A. Kurt-Jones, R. W. Finberg
This study identifies ADAM9 as a host factor required for early stages of EMCV infection using CRISPR-Cas9 screening, showing resistance in ADAM9 knockout cells.
bioRxiv · Dec 9, 2018Microbiology